02:27 , May 18, 2018 |  BC Week In Review  |  Financial News

Acousia raises $12M in series B

Hearing loss company Acousia Therapeutics GmbH (Tübingen, Germany) raised €10 million ($12 million) on May 14 in a series B round led by LBBW Venture Capital. Fellow new investors Creathor Ventures and Bregua Corp. and...
12:05 , May 14, 2018 |  BC Extra  |  Financial News

Acousia raises €10M in series B

Hearing loss company Acousia Therapeutics GmbH (Tübingen, Germany) raised €10 million ($12 million) in a series B round led by LBBW Venture Capital. Fellow new investors Creathor Ventures and Bregua Corp. and existing investors Boehringer...
07:00 , Oct 3, 2016 |  BioCentury  |  Finance

Avalon's academic ADC

Avalon Ventures' latest academic deal has yielded a newco with an antibody-drug conjugate that will have Phase I data in two indications within the next three years. Last week, the VC led an $18 million...
07:00 , Oct 3, 2016 |  BC Week In Review  |  Financial News

Fortis Therapeutics completes venture financing

Fortis Therapeutics Inc. , La Jolla, Calif.   Business: Cancer   Date completed: 2016-09-27   Type: Venture financing   Raised: $18 million   Investors: Avalon Ventures; Bregua; Lilly Asia Ventures; Osage University Partners; Vivo Capital...
07:00 , Sep 27, 2016 |  BC Extra  |  Financial News

Fortis debuts with $18M series A

Avalon Ventures launched immuno-oncology play Fortis Therapeutics Inc. (San Diego, Calif.) and led the newco's $18 million series A round. Bregua Corp., Lilly Asia Ventures, Osage University Partners and Vivo Capital also participated. Fortis' unnamed...
07:00 , Aug 22, 2016 |  BC Week In Review  |  Financial News

Avelas Biosciences completes venture financing

Avelas Biosciences Inc. , La Jolla, Calif.   Business: Cancer, Diagnostic   Date completed: 2016-08-18   Type: Venture financing   Raised: $20 million   Investors: Pharmstandard International S.A.; Ervington Investments; Alexandria Venture Investments; Avalon Ventures;...
07:00 , Aug 18, 2016 |  BC Extra  |  Financial News

Avelas' series C round brings in $20M

Avelas Biosciences Inc. (La Jolla, Calif.) raised $20 million in a series C financing led by the Pharmstandard International S.A. subsidiary of Pharmstandard OJSC (RTS:PHST; LSE:PHST). New investors Ervington Investments and Alexandria Venture Investments participated,...